Aspiriant LLC’s Vanguard Mid-Cap ETF VO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Buy
23,588
+48
+0.2% +$3.57K 0.05% 124
2025
Q4
$1.71M Buy
23,540
+9,900
+73% +$720K 0.05% 126
2025
Q3
$1M Hold
13,640
0.03% 145
2025
Q2
$954K Sell
13,640
-2,284
-14% -$150K 0.03% 150
2025
Q1
$1.03M Sell
15,924
-596
-4% -$40K 0.04% 140
2024
Q4
$1.09M Sell
16,520
-2,252
-12% -$153K 0.04% 134
2024
Q3
$1.24M Sell
18,772
-736
-4% -$46.2K 0.05% 129
2024
Q2
$1.18M Sell
19,508
-1,272
-6% -$77.3K 0.05% 131
2024
Q1
$1.3M Sell
20,780
-1,260
-6% -$74.5K 0.05% 127
2023
Q4
$1.28M Hold
22,040
0.06% 125
2023
Q3
$1.15M Sell
22,040
-1,624
-7% -$89.1K 0.06% 123
2023
Q2
$1.3M Sell
23,664
-156
-0.7% -$8.18K 0.07% 109
2023
Q1
$1.26M Sell
23,820
-576
-2% -$30.6K 0.07% 113
2022
Q4
$1.24M Buy
24,396
+3,540
+17% +$180K 0.06% 113
2022
Q3
$980K Sell
20,856
-112
-0.5% -$5.85K 0.05% 122
2022
Q2
$1.03M Sell
20,968
-2,096
-9% -$113K 0.05% 119
2022
Q1
$1.37M Buy
23,064
+7,368
+47% +$432K 0.08% 109
2021
Q4
$1M Buy
15,696
+2,428
+18% +$152K 0.05% 133
2021
Q3
$784K Buy
13,268
+476
+4% +$28.8K 0.05% 134
2021
Q2
$758K Buy
+12,792
New +$741K 0.04% 134
2016
Q3
Sell
-14,660
Closed -$453K 201
2016
Q2
$453K Buy
+14,660
New +$448K 0.04% 143

Other funds holding VO

Aspiriant LLC's VO Position: Q1 2026 in Review

Aspiriant LLC increased its Vanguard Mid-Cap ETF (VO) stake by 0.2% in Q1 2026, buying an estimated $3.57K and bringing the position to 23,588 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #124.

Aspiriant LLC first reported a position in VO in Q2 2016 and has held it in 21 quarters since. The position peaked at $1.71M in Q4 2025. 2,384 funds tracked by Wall St. Rank hold VO as of Q1 2026.

  • Aspiriant LLC held 23,588 shares of Vanguard Mid-Cap ETF worth $1.69M as of Q1 2026.
  • Aspiriant LLC bought 48 Vanguard Mid-Cap ETF shares in Q1 2026, an estimated $3.57K.
  • Vanguard Mid-Cap ETF made up 0.05% of Aspiriant LLC's portfolio in Q1 2026, its #124 holding.
  • Aspiriant LLC first reported a position in Vanguard Mid-Cap ETF in Q2 2016 and has held it in 21 quarters since.
  • Aspiriant LLC's Vanguard Mid-Cap ETF position peaked at $1.71M in Q4 2025.
  • 2,384 funds tracked by Wall St. Rank held Vanguard Mid-Cap ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.